Literature DB >> 3805531

How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men.

M Packer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3805531     DOI: 10.1016/s0735-1097(87)80400-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  12 in total

1.  Changes in AVP following aggressive diuretic therapy of severe congestive cardiac failure in elderly patients.

Authors:  E Mulkerrin; M D Penney; K Donovan; D Hampton; J Arnold; D Sykes
Journal:  Postgrad Med J       Date:  1991-12       Impact factor: 2.401

Review 2.  Quality of life instruments in the evaluation of new drugs.

Authors:  R Jaeschke; G H Guyatt; D Cook
Journal:  Pharmacoeconomics       Date:  1992-02       Impact factor: 4.981

3.  Cardiac neuronal imaging with ¹²³I-meta-iodobenzylguanidine in heart failure: implications of endpoint selection and quantitative analysis on clinical decisions.

Authors:  Mario Petretta; Teresa Pellegrino; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-11       Impact factor: 9.236

4.  The effects of flosequinan on submaximal exercise in patients with chronic cardiac failure.

Authors:  J S Elborn; M Riley; C F Stanford; D P Nicholls
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

Review 5.  Haemodynamic effects of diuretics in heart failure.

Authors:  E B Raftery
Journal:  Br Heart J       Date:  1994-08

6.  Einstein, the Blind Men, and the Elephant: Making Sense of Heart Failure With Preserved Ejection Fraction.

Authors:  Scott L Hummel
Journal:  J Card Fail       Date:  2016-10-17       Impact factor: 5.712

Review 7.  HCFA's health care quality improvement program: the medical informatics challenge.

Authors:  J B Grant; R P Hayes; R D Pates; K S Elward; D J Ballard
Journal:  J Am Med Inform Assoc       Date:  1996 Jan-Feb       Impact factor: 4.497

8.  The effects of afterload reduction on myocardial carbon 11-labeled acetate kinetics and noninvasively estimated mechanical efficiency in patients with dilated cardiomyopathy.

Authors:  R S Beanlands; W F Armstrong; R J Hicks; J Nicklas; C Moore; G D Hutchins; H G Wolpers; M Schwaiger
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

Review 9.  Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.

Authors:  A Fitton; R N Brogden
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

10.  Does digitalis work in chronic heart failure? The end of a 200-year-old controversy.

Authors:  M Packer
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.